TOI Chief Clinical Officer granted 70,270 RSUs
Langsam Jeffrey reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Langsam Jeffrey reported acquisition or exercise transactions in this Form 4 filing.
Oncology Institute, Inc. reported that its Chief Clinical Officer, Jeffrey Langsam, received a grant of 70,270 shares of common stock in the form of restricted stock units. These RSUs were granted at no cash cost per share and increase his direct holdings to 127,650 shares after the award.
The footnote explains that one quarter of the RSUs will vest on the first anniversary of the Vesting Commencement Date, with the remaining units vesting in three equal annual installments on each of the next three anniversaries. All RSUs are subject to continued service with the company through the respective vesting dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 70,270 shares
Grant/Award
1 txn
Insider
Langsam Jeffrey
Role
Chief Clinical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 70,270 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 127,650 shares (Direct)
Footnotes (1)
- F1. Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Key Figures
RSU grant size: 70,270 shares
Post-transaction holdings: 127,650 shares
Grant price per share: $0.0000 per share
+2 more
5 metrics
RSU grant size
70,270 shares
Restricted stock unit award to Chief Clinical Officer
Post-transaction holdings
127,650 shares
Total common stock held directly after RSU grant
Grant price per share
$0.0000 per share
Reported transaction price for RSU award
Initial vesting
1/4 of RSUs
Vests on first anniversary of Vesting Commencement Date
Remaining vesting schedule
3 equal annual installments
After first anniversary, over next three anniversaries
Key Terms
Restricted Stock Units (RSUs), Vesting Commencement Date, continued service, Common Stock
4 terms
Restricted Stock Units (RSUs) financial
"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Vesting Commencement Date financial
"on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
continued service financial
"subject to continued service with the Company through such vesting dates"
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TOI disclose for Jeffrey Langsam on this Form 4?
TOI disclosed that Chief Clinical Officer Jeffrey Langsam received a grant of 70,270 restricted stock units of common stock. The award was reported as an acquisition at no cash cost per share and increased his directly held position to 127,650 shares after the transaction.
How do the TOI restricted stock units granted to Jeffrey Langsam vest over time?
The RSUs vest over four years. One quarter of the units vests on the first anniversary of the Vesting Commencement Date, and the remaining RSUs vest in three equal annual installments on each of the next three anniversaries, subject to his continued service with the company.
Did Jeffrey Langsam pay any purchase price for the TOI RSU award?
No cash purchase price is associated with this RSU award, as the transaction price per share is reported as 0.0000. Restricted stock units are typically granted as part of equity compensation and convert into shares upon vesting if the service conditions are satisfied.
What role does Jeffrey Langsam hold at Oncology Institute, Inc. in this filing?
In this filing, Jeffrey Langsam is identified as an officer of Oncology Institute, Inc., serving as Chief Clinical Officer. The reported RSU award reflects part of his equity-based compensation and is subject to multi-year vesting tied to continued service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
